# National Taiwan University Hospital

Source: https://onco.cc/institutions/ntuh/  
OnCo record `ntuh` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Taiwan's leading academic hospital and the birthplace of the hepatitis B vaccination programme that cut childhood liver cancer, with a new dedicated cancer centre.

## Summary

NTUH, founded in 1895, is the teaching hospital of National Taiwan University College of Medicine and opened the National Taiwan University Cancer Center in 2019 with proton therapy. NTU investigators led the world's first national hepatitis B vaccination programme and the epidemiological studies (Ding-Shinn Chen, Mei-Hwei Chang) demonstrating its effect on hepatocellular carcinoma incidence, and its liver, lung (James Chih-Hsin Yang's EGFR trials including LUX-Lung and FLAURA), breast (Ann-Lii Cheng, Chiun-Shen Huang) and haematology groups are among Asia's most cited. Pei-Jer Chen and Ann-Lii Cheng have led global HCC trials of sorafenib, lenvatinib and atezolizumab-bevacizumab. The hospital runs Taiwan's largest cell therapy and transplant programmes and an early-phase unit.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: NTUH; 臺大醫院; National Taiwan University Cancer Center
- City: Taipei, TW
- Type: hospital
- Website: https://www.ntuh.gov.tw

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/National_Taiwan_University_Hospital
- NTUH: https://www.ntuh.gov.tw
- NTU Cancer Center: https://www.ntucc.gov.tw
- NTU College of Medicine: https://www.mc.ntu.edu.tw

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/), [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/), [Radiation Therapy](https://onco.cc/fronts/radiation/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- targets: [EGFR](https://onco.cc/targets/egfr/), [PD-L1](https://onco.cc/targets/pdl1/), [VEGF / VEGFR](https://onco.cc/targets/vegf/)
- drugs: [Afatinib](https://onco.cc/drugs/afatinib/), [Atezolizumab](https://onco.cc/drugs/atezolizumab/), [Osimertinib](https://onco.cc/drugs/osimertinib/)
- people: [Ann-Lii Cheng](https://onco.cc/people/ann-lii-cheng/), [Chong-Jen Yu](https://onco.cc/people/chong-jen-yu/)

---
JSON: https://onco.cc/api/v1/entities/ntuh.json